IRIS Accounts Production v24.1.9.2 04585697 Board of Directors 1.3.23 29.2.24 29.2.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh045856972023-02-28045856972024-02-29045856972023-03-012024-02-29045856972022-02-28045856972022-03-012023-02-28045856972023-02-2804585697ns15:EnglandWales2023-03-012024-02-2904585697ns14:PoundSterling2023-03-012024-02-2904585697ns10:Director12023-03-012024-02-2904585697ns10:PrivateLimitedCompanyLtd2023-03-012024-02-2904585697ns10:SmallEntities2023-03-012024-02-2904585697ns10:AuditExempt-NoAccountantsReport2023-03-012024-02-2904585697ns10:SmallCompaniesRegimeForDirectorsReport2023-03-012024-02-2904585697ns10:SmallCompaniesRegimeForAccounts2023-03-012024-02-2904585697ns10:FullAccounts2023-03-012024-02-290458569712023-03-012024-02-2904585697ns10:Director22023-03-012024-02-2904585697ns10:CompanySecretary12023-03-012024-02-2904585697ns10:RegisteredOffice2023-03-012024-02-2904585697ns5:CurrentFinancialInstruments2024-02-2904585697ns5:CurrentFinancialInstruments2023-02-2804585697ns5:ShareCapital2024-02-2904585697ns5:ShareCapital2023-02-2804585697ns5:RetainedEarningsAccumulatedLosses2024-02-2904585697ns5:RetainedEarningsAccumulatedLosses2023-02-2804585697ns5:NetGoodwill2023-03-012024-02-2904585697ns5:NetGoodwill2023-02-2804585697ns5:NetGoodwill2024-02-2904585697ns5:NetGoodwill2023-02-2804585697ns5:LandBuildings2023-02-2804585697ns5:PlantMachinery2023-02-2804585697ns5:LandBuildings2023-03-012024-02-2904585697ns5:PlantMachinery2023-03-012024-02-2904585697ns5:LandBuildings2024-02-2904585697ns5:PlantMachinery2024-02-2904585697ns5:LandBuildings2023-02-2804585697ns5:PlantMachinery2023-02-2804585697ns5:CostValuation2023-02-2804585697ns5:AdditionsToInvestments2024-02-2904585697ns5:DisposalsRepaymentsInvestments2024-02-2904585697ns5:RevaluationsIncreaseDecreaseInInvestments2024-02-2904585697ns5:CostValuation2024-02-2904585697ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-02-2904585697ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-02-28
REGISTERED NUMBER: 04585697 (England and Wales)















Unaudited Financial Statements for the Year Ended 29 February 2024

for

Aum Healthcare Limited

Aum Healthcare Limited (Registered number: 04585697)

Contents of the Financial Statements
for the Year Ended 29 February 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Aum Healthcare Limited

Company Information
for the Year Ended 29 February 2024







DIRECTORS: Mr P N Patel
Mrs A Patel





SECRETARY: Mrs A Patel





REGISTERED OFFICE: Office 1
21 Hatherton Street
Walsall
WS4 2LA





REGISTERED NUMBER: 04585697 (England and Wales)





ACCOUNTANTS: Dhillon Accountants Limited
Chartered Accountants
Office 1
21 Hatherton Street
Walsall
WS4 2LA

Aum Healthcare Limited (Registered number: 04585697)

Balance Sheet
29 February 2024

29.2.24 28.2.23
Notes £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 74,862 79,180
Investments 6 103,728 95,040
178,590 174,220

CURRENT ASSETS
Stocks 54,510 63,350
Debtors 7 1,293,220 1,078,437
Cash at bank and in hand 299,248 296,572
1,646,978 1,438,359
CREDITORS
Amounts falling due within one year 8 (392,368 ) (334,782 )
NET CURRENT ASSETS 1,254,610 1,103,577
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,433,200

1,277,797

PROVISIONS FOR LIABILITIES (8,565 ) (6,539 )
NET ASSETS 1,424,635 1,271,258

CAPITAL AND RESERVES
Called up share capital 102 102
Retained earnings 1,424,533 1,271,156
SHAREHOLDERS' FUNDS 1,424,635 1,271,258

Aum Healthcare Limited (Registered number: 04585697)

Balance Sheet - continued
29 February 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 29 February 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 29 February 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 September 2024 and were signed on its behalf by:





Mr P N Patel - Director


Aum Healthcare Limited (Registered number: 04585697)

Notes to the Financial Statements
for the Year Ended 29 February 2024


1. STATUTORY INFORMATION

Aum Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover comprises revenue recognised by the company in the company in respect of goods and services supplied by the company, net of Value Added Tax and trade discounts.

Goodwill
Goodwill is the difference between amounts paid on the acquisition of a business and the fair value of the separable net assets. It has been fully amortised over its estimated economic life.

Tangible fixed assets
Tangible assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:-

Leasehold5% Straight Line
Office equipments15% Reducing Balance
Fixtures & Fittings15% Reducing Balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.


Aum Healthcare Limited (Registered number: 04585697)

Notes to the Financial Statements - continued
for the Year Ended 29 February 2024


2. ACCOUNTING POLICIES - continued
Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.

Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 18 (2023 - 15 ) .

Aum Healthcare Limited (Registered number: 04585697)

Notes to the Financial Statements - continued
for the Year Ended 29 February 2024


4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 March 2023
and 29 February 2024 344,908
AMORTISATION
At 1 March 2023
and 29 February 2024 344,908
NET BOOK VALUE
At 29 February 2024 -
At 28 February 2023 -

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 March 2023 83,217 139,570 222,787
Additions - 5,304 5,304
At 29 February 2024 83,217 144,874 228,091
DEPRECIATION
At 1 March 2023 38,452 105,155 143,607
Charge for year 4,161 5,461 9,622
At 29 February 2024 42,613 110,616 153,229
NET BOOK VALUE
At 29 February 2024 40,604 34,258 74,862
At 28 February 2023 44,765 34,415 79,180

Aum Healthcare Limited (Registered number: 04585697)

Notes to the Financial Statements - continued
for the Year Ended 29 February 2024


6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
At 1 March 2023 95,040
Additions 2,986
Disposals (2,224 )
Revaluations 7,926
At 29 February 2024 103,728
NET BOOK VALUE
At 29 February 2024 103,728
At 28 February 2023 95,040


7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
29.2.24 28.2.23
£    £   
Trade debtors 133,337 129,242
Other debtors 1,159,883 949,195
1,293,220 1,078,437

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
29.2.24 28.2.23
£    £   
Trade creditors 168,061 175,567
Taxation and social security 76,409 45,361
Other creditors 147,898 113,854
392,368 334,782

9. RELATED PARTY DISCLOSURES

As of 28 February 2024, the company was owed £826,528.49 (2023 - £802,354.85) by AUM Group Limited.
Interest is charged at 3%. The loan is repayable on demand.

The company was also owed £308,542 (2023 - £121,588) by Relinquo Holdings Limited as of 29 February 2024. Interest is charged at 3%. The loan is repayable on demand.

Mr P Patel and Mrs A Patel were the directors of Aum Group and Relinquo Holdings Limited as of 29 February 2024.

Aum Healthcare Limited (Registered number: 04585697)

Notes to the Financial Statements - continued
for the Year Ended 29 February 2024


10. ULTIMATE CONTROLLING PARTY

The company is jointly controlled by Mr P and Mrs A Patel, by virtue of their ownership of 100% of the issued share capital in the company.